Skip to main content
ANNX logo

Annexon, Inc.

ANNXNASDAQHealthcareBiotechnology

$3.42Today:- (-)1Y +14.29%

As of Oct 16, 2026 close

Market cap
$723.61M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.54$7.18
Volume (live)
-
Avg. volume (3M)
3.39M

Annexon (ANNX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Annexon used $186.36M of cash in operating activities and spent $137.00K on capital expenditures. That left free cash flow of −$186.49M. It paid $1.86M in dividends.

Annexon Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Annexon, Inc. (ANNX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-206.69-138.20-134.24-141.95-130.32-63.41-37.18-18.30-18.71
Depreciation & Amortization2.172.152.152.112.140.670.490.490.27
Stock Based Compensation16.4219.4318.1818.5216.264.892.040.410.40
Change in Working Capital4.236.36-5.813.743.284.720.630.48-1.22
Change in Accounts Payable4.494.94-2.08-0.293.861.510.93-0.250.14
Change in Other Working Capital-0.26-5.87-3.73-2.151.273.20-0.310.73-1.37
Other Operating Activities-2.49-7.75-1.431.281.270.055.67-0.260.80
Net Cash from Operating Activities-186.36-118.01-121.14-116.31-106.11-53.09-28.36-17.19-19.26
Investing Activities
Capital Expenditures-0.14-0.02-0.19-6.53-1.65-0.46-0.27-0.02-0.57
Purchases of Investments-212.21-583.93-108.09-113.20-225.60-82.700.000.000.00
Sales/Maturities of Investments402.40365.15178.98178.17139.020.000.000.000.00
Net Cash from Investing Activities190.05-218.8070.7058.44-88.24-83.16-0.27-0.02-0.57
Financing Activities
Debt Repayment0.000.000.000.000.00-0.500.000.000.00
Common Stock Issued110.47163.47135.51130.901.80267.040.0058.460.04
Dividends Paid-1.860.000.000.000.00-6.220.000.000.00
Other Financing Activities0.24-2.260.01-7.990.00-8.1728.4058.460.04
Net Cash from Financing Activities108.86161.21135.52122.911.80360.8828.4058.460.04
Summary
Effect of Forex Changes on Cash0.00-0.020.010.000.000.01-0.01-0.04-0.02
Net Change in Cash112.55-175.6185.0965.04-192.55224.63-0.2441.21-19.81
Cash at Beginning of Period50.53226.14141.0576.01268.5743.9344.182.9722.78
Cash at End of Period163.0850.53226.14141.0576.01268.5743.9344.182.97
Free Cash Flow-186.49-118.02-121.34-122.84-107.76-53.55-28.63-17.21-19.83

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Annexon Cash Flow

What is Annexon's free cash flow?

Annexon had negative free cash flow of $186.49M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$186.36M minus $137.00K of capital expenditures.

How much does Annexon spend on capital expenditures?

Annexon spent $137.00K on capital expenditures in fiscal 2025, compared with $15.00K a year earlier.

Does Annexon pay dividends or buy back shares?

Yes. In fiscal 2025 Annexon returned $1.86M in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition